PRE Prenetics Global: Company Long-Term Indebtedness

Official company branding of Prenetics (PRE)

This daily price chart for Prenetics Global (PRE) long-term debt is fixed at 0.00. The company, which specializes in diagnostic research, is implementing eco-packaging and minimizing plastic in its test systems. Additionally, the business is optimizing bio-waste disposal and digitizing the delivery of results. The enterprise's financial success relies on test accuracy, the development of the genetic sector, and lucrative corporate contracts.

PRE (Prenetics Global Ltd) Company Long-Term Debt history from 04/28/2023 to 10/28/2026

Analytical breakdowns for Prenetics (PRE)

- price and consensus price forecast:
Stock Price Prenetics Global Limited|PRE - Price Target Chart
- market capitalization data:
Market Capitalization Prenetics|PRE - Enterprise Value
- book capitalization data:
Book Value per Share Prenetics|PRE - Company Book Value|Market Value to Book Value Ratio prenetics.com|PRE - Cumulative Company Assets
- debt and liquidity data:
Debt to Capital Prenetics Global|PRE - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Prenetics Global Limited|PRE - Company Aggregate Debts|Debts to Net Assets Prenetics|PRE - Company Long-Term Debt|Short-Term Debt Volume Prenetics
General company analysis:Prenetics Global (PRE)
Manufactured products of Prenetics Global

Prenetics Global derives its advantage from the transition toward the commercialization of high-tech liquid biopsy systems. By analyzing the company's long-term borrowings, an investor can identify the volume of liabilities with a maturity exceeding one year. This indicator captures the actual debt load, eliminating subjective assessments. The trend of this metric determines whether external financing is sufficient to scale IT platforms without a critical risk of default.

Competing companies

agilent.com - Company Long-Term Debts|Quest Diagnostics Incorporated (DGX) - Company Long-Term Debt|ILMN - Company Long-Term Indebtedness|EXAS: Company Long-Term Debts|RVTY (Revvity Corp) - Company Long-Term Debts|Company Long-Term Debt Bio-Rad Laboratories|Company Long-Term Debt anbio.com (NNNN)|Sotera Health - Company Long-Term Liabilities|Long-Term Debt QDEL (Quidel Corporation)|Company Long-Term Debt OPK|Long-Term Debt Volume CareDx CDNA|Company Long-Term Debts MRVI (Maravai LifeSciences)|FLGT: Long-Term Debt Volume|Standard BioTools - Company Long-Term Debt|CTKB (Cytek Biosciences Inc) - Long-Term Debt Volume|Company Long-Term Debt OraSure Technologies Inc OSUR|Long-Term Liabilities XGN|MDxHealth SA (MDXH) - Company Long-Term Debt|Company Long-Term Loans and Borrowings luciddx.com (LUCD)|IMDX: Company Long-Term Debts|Trinity Biotech PLC - Long-Term Debt|ProPhase (PRPH) - Company Long-Term Debt|AIMD - Company Long-Term Indebtedness|Company Long-Term Debts CODX|Long-Term Debt heartsciences.com|Biomerica (BMRA) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Cardio Diagnostics Holdings, Inc.|VRAX (Virax Biolabs Group Ltd) - Company Long-Term Debts|Long-Term Debt Volume Bluejay Diagnostics Corp (BJDX)|Aspira Women's Health - Company Long-Term Debts|acceleratediagnostics.com - Company Long-Term Liabilities|Company Long-Term Debt CNTG (CENTOGENE)|Enzo Biochem, Inc. (ENZ) - Long-Term Debt Volume|Company Long-Term Liabilities fresh2.co FRES|Genetic Technologies Limited (GENE) - Company Long-Term Loans and Borrowings|23andMe Holding Co. - Company Long-Term Debts|Long-Term Indebtedness PMD